NVS

Novartis AG

$150.17 -0.81%

Recent alerts on NVS

All signals →

News Closing the gates? Upcoming Swiss referendum has tech and pharma alarmed

News Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag

News International ETFs: EEM and IEFA Offer Distinct Global ETF Choices

News Novartis Bets $2 Billion To Deepen Allergy Drug Pipeline

News Trump's New Tariff Barrage Targets Drugs, Trucks, Cabinets: President Says Move Will Protect Manufacturers From 'Unfair Outside Competition'

News Pharma's Direct-To-Patient Wave Hits Novartis Next

News Novartis Positions US Strategy As Defense Against Rising Trade Levies

News Monte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease Treatments

News Roche Targets Top Spot In Weight Loss Drug Market

News Novartis To Expand Heart Drug Portfolio With $1.4 Billion Tourmaline Bio Acquisition

News Novartis Stock Rallies on Radioligand Breakthrough, but Valuation Risks Loom

News Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm

News UK Drug Pricing Talks Collapse, Drugmakers Reject Offer Citing 'Uncompetitive' System

News Novartis' Investigational Drug Aces Two Pivotal Trials For Chronic Disease Impacting Tears, Saliva

News Biogen Lifts Outlook As Rare Disease And Alzheimer's Drug Sales Accelerate

News Novartis Raises Operating Income Outlook After Strong Q2 Performance, Initiates $10 Billion Stock Buyback (CORRECTED)

News Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million

News Roche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs

News Novartis Q1 Earnings Beat Street View, CEO 'Confident' In Delivering Upgraded Guidance

News Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties

News Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy

News FDA Approves Expanded Use Of Novartis Rare Disease Drug As Only Treatment For Rare Type Of Kidney Disease

News Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed

News NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects

News Novartis Q4: Earnings Beat Estimates, CEO Dismisses Entresto Patent Expiration Worries

Get push alerts for NVS

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS